Departure creates a headache for investors in the Slough-based company, which makes Nurofen pain killers among a range of household-name products
(Picture: Jason Reed/Reuters)The shock departure of Reckitt Benckiser’s well-regarded chief executive after just three years in the job has hit shares in the maker of household-name products from Cillit Bang to Nurofen.
Laxman Narasimhan is stepping down from the FTSE 100 multinational citing family reasons and “an opportunity” to return to his native US, which City observers interpreted as a sign he could be headed for a new job on the other side of the Atlantic.
